The GenoRx Program uses Pharmacogenomics, or PGx testing to study an individual's response to drugs. We’ve learned through research that genes play a role in how the body responds to medications. PGx testing can lead to more informed prescribing, increased medication adherence, and reduce the trial and error for treatments prescribed to manage many common conditions like cardiovascular disease, depression and anxiety, cancer, infectious disease, pain, and many others.

The GenoRx Program is introducing PGx testing to personalize medication treatment in three strategic areas:

1. Mental health prescribing,
2. Clopidogrel and cardiovascular events, and
3. Polypharmacy to optimize prescribing for patients over 65 who are on multiplechronic medications.

Download Brochure

Learn More

No items found.
No items found.

Learn more

Stay up to date on our research by following some of our primary researchers:

Bill Wright, PhD

Selected Works
  • Vice President of Health Innovation Research, Providence

Carlo Bifulco, MD

Selected Works
  • Member and Director, Translational Molecular Pathology and Molecular Genomics
  • Medical director, Molecular Genomics Laboratory, Providence St. Joseph Health Anatomic & Molecular Genetic Pathology

Brian D. Piening, PhD

Selected Works
  • Assistant member, Cancer Immuno-Genomics Laboratory
  • Technical Director, Molecular Genomics Laboratory, Providence St. Joseph Health